Internal Medicine, Pulmonary Disease · Slidell, LA
NPI
1780685453
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1850 Gause Blvd E, Suite 202
Slidell, LA, 70461
Phone (985) 639-3777
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
1,114 services
Medicare patients, 2024
413
Average age 73
Drug cost, 2024
$4.5M
9,516 prescriptions
Company payments, 2025
$3,436
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dennis M Dale was code 99213 (office e&m - established), 305 times for 201 patients. In total Dennis M Dale billed 1,114 services in 19 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 305 | 201 | $46.88 | $14K |
| 99214 Office E&M - Established | Office | 153 | 103 | $67.06 | $10K |
| 94729 Pulmonary Function Testing | Facility | 106 | 102 | $6.39 | $678 |
| 94726 Pulmonary Function Testing | Facility | 104 | 102 | $8.60 | $894 |
| 94618 Pulmonary Function Testing | Facility | 103 | 96 | $15.77 | $1,624 |
| 94060 Pulmonary Function Testing | Facility | 89 | 89 | $7.34 | $653 |
| 99215 Office E&M - Established | Office | 87 | 76 | $99.81 | $8,684 |
| 99212 Office E&M - Established | Office | 52 | 36 | $28.06 | $1,459 |
| 99203 Office E&M - New | Office | 28 | 28 | $59.70 | $1,672 |
| 94010 Pulmonary Function Testing | Facility | 28 | 24 | $6.07 | $170 |
| 99204 Office E&M - New | Office | 16 | 16 | $93.63 | $1,498 |
By year: 2022 $84K for 1,510 services; 2023 $48K for 1,069 services; 2024 $44K for 1,114 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dennis M Dale prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 1,416 prescriptions and refills. In total Dennis M Dale wrote 9,516 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,416 | 1,833 | 339 | $1.2M |
| Prednisone Generic | 1,066 | 1,196 | 455 | $4,148 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,026 | 1,248 | 367 | $39K |
| Montelukast Sodium Generic | 461 | 975 | 114 | $2,969 |
| Azithromycin Generic | 427 | 481 | 167 | $4,541 |
| Alprazolam Generic | 361 | 386 | 74 | $2,136 |
| Doxycycline Hyclate Generic | 294 | 326 | 138 | $3,296 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 203 | 267 | 71 | $166K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 201 | 201 | 44 | $3,705 |
| Fluticasone Propionate Generic | 193 | 342 | 70 | $2,492 |
| Dupixent Pen Dupilumab | 169 | 169 | 26 | $652K |
| Ventolin Hfa Albuterol Sulfate | 164 | 183 | 47 | $12K |
| Furosemide Generic | 132 | 187 | 43 | $488 |
| Nucala Mepolizumab | 120 | 120 | 17 | $463K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 118 | 118 | 54 | $1,605 |
Brand drugs: 3,436 claims; generic drugs: 6,080 claims; opioid claims: 266.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dennis M Dale $3,436 ($3,436 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $977.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 47 | $977 |
| GlaxoSmithKline, LLC. GSK | 42 | $609 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $281 |
| Genzyme Corporation SNY | 13 | $275 |
| Grifols USA, LLC | 10 | $268 |
| Verona Pharma, Inc. VRNA | 11 | $163 |
| United Therapeutics Corporation UTHR | 6 | $126 |
| Viatris Specialty LLC | 5 | $125 |
| Amgen Inc. AMGN | 5 | $109 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $97.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.